Hepcidin and anemia of the critically ill patient: Bench to bedside

Anesthesiology

Volumn 114, Issue 3, 2011, Pages 688-694

  Lasocki, Sigismond ^a   Longrois, Dan ^a   Montravers, Philippe ^a   Beaumont, Carole ^b  

^a BICHAT HOSPITAL   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ASCORBIC ACID; ERYTHROCYTE ZINC PROTOPORPHYRIN; FERRITIN; FERROUS ION; HEPCIDIN; IRON; PROTON PUMP INHIBITOR; PROTOPORPHYRIN ZINC; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANEMIA; BLEEDING; BLOOD ANALYSIS; BLOOD TRANSFUSION; CRITICALLY ILL PATIENT; DRUG ABSORPTION; DRUG EFFICACY; DRUG INHIBITION; DRUG MEGADOSE; DRUG SYNTHESIS; ERYTHROID CELL; ERYTHROPHAGOCYTOSIS; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON TRANSPORT; LENGTH OF STAY; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REHABILITATION CARE; RISK FACTOR; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 79952041796     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182065c57     Document Type: Note

References (25)

1. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D, ABC (Anemia and Blood Transfusion in Critical Care) Investigators: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-507
2. Walsh TS, Lee RJ, Maciver CR, Garrioch M, Mackirdy F, Binning AR, Cole S, McClelland DB: Anemia during and at discharge from intensive care: The impact of restrictive blood transfusion practice. Intensive Care Med 2006; 32:100-9 (Pubitemid 43039383)
3. Bateman AP, McArdle F, Walsh TS: Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009; 37:1906-12
4. Spahn DR: Anemia and patient blood management in hip and knee surgery: A systematic review of the literature. ANESTHESIOLOGY 2010; 113:482-95
5. Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA: Erythropoietin- receptor agonists in critically ill patients: A meta-analysis of randomized controlled trials. CMAJ 2007; 177:725-34 (Pubitemid 47523553)
6. Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 2005; 352:1011-23
7. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28:2773-8
8. von Ahsen N, Müller C, Serke S, Frei U, Eckardt KU: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27:2630-9 (Pubitemid 30027173)
9. Pieracci FM, Barie PS: Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006; 34:1898-905 (Pubitemid 43982465)
10. Fernandez R, Tubau I, Masip J, Muñoz L, Roig I, Artigas A: Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: A cohort study. ANESTHESIOLOGY 2010; 112:1211-5
11. Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, Beaumont C, Montravers P: Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med 2010; 36:1044-8
12. Finch C: Regulators of iron balance in humans. Blood 1994; 84:1697-702
13. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110:1037-44
14. Hentze MW, Muckenthaler MU, Galy B, Camaschella C: Two to tango: Regulation of mammalian iron metabolism. Cell 2010; 142:24-38
15. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, López-Otín C: Matriptase-2 (TMPRSS6): A proteolytic regulator of iron homeostasis. Haematologica 2009; 94:840-9
16. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH, Eling TE, Childs R, Ganz T, Leitman SF, Fucharoen S, Miller JL: High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007; 13:1096-101 (Pubitemid 47517510)
17. Huang H, Constante M, Layoun A, Santos MM: Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009; 113:3593-9
18. Lasocki S, Millot S, Andrieu V, Lettéron P, Pilard N, Muzeau F, Thibaudeau O, Montravers P, Beaumont C: Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 2008; 36:2388-94
19. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G: Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications. Blood; 2009; 113:5277-86
20. Ray P, Le Manach Y, Riou B, Houle TT: Statistical evaluation of a biomarker [published online ahead of print March 15, 2010]. ANESTHESIOLOGY
21. Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, Hider RC, Koliaraki V, Mamalaki A, Olbina G, Tomosugi N, Tselepis C, Ward DG, Ganz T, Hendriks JC, Swinkels DW: Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization. Haematologica 2009; 94:1748-52
22. Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM: Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia [published online ahead of print May 25, 2010]. Clin Exp Med
23. Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A, Critical Care Clinical Trials Greek Group: Recombinant human erythropoietin therapy in critically ill patients: A dose-response study [ISRCTN48523317]. Crit Care 2005; 9:R508-15
24. Auerbach M, Ballard H, Glaspy J: Clinical update: Intravenous iron for anaemia. Lancet 2007; 369:1502-4 (Pubitemid 46670290)
25. Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS: Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect 2009; 10:9-19